PPC vs REGN · P/E 7.6, rev $17.88B vs P/E 14, rev $14.34B
Pilgrims Pride Corp (PPC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Pilgrims Pride Corp (PPC) is a packaged foods company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PPC revenue for 2024-12-29 was $17.88B. Net income was $1.09B. Revenue was up 3.0% from 2023-12-31 to 2024-12-29. PPC currently screens at market cap $6.75B and trailing P/E 7.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PPC currently screens at market cap $6.75B and trailing P/E 7.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PPC and REGN stock pages for the full models.
Not investment advice.